Q&A With Monika Fischer From Indiana University: Tackling New Challenges In Gastroenterology

JANUARY 05, 2016
Amy Jacob

Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.

Monika Fischer, MD, from Indiana University discussed some of the latest research in this field during the annual meeting of the American College of Gastroenterology in Hawaii.

As fecal microbiota transplant becomes a more common procedure to treat patients with gastrointestinal issues new questions are being answered about factors that can affect its success.

Related Coverage >>>
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.